4//SEC Filing
Lev Pharmaceuticals Inc 4
Accession 0001144204-08-000556
CIK 0001144062operating
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 7:20 PM ET
Size
10.1 KB
Accession
0001144204-08-000556
Insider Transaction Report
Form 4
Lev Pharmaceuticals IncLEVP.OB
COOPER JUDSON A
DirectorChairman and EVP10% Owner
Transactions
- Gift
Common Stock
2007-12-31−90,000→ 27,383,417 total(indirect: See footnotes) - Gift
Common Stock
2007-12-31+30,000→ 458,235 total(indirect: See footnote) - Gift
Common Stock
2008-01-03−90,000→ 27,293,417 total(indirect: See footnotes)
Holdings
- 2,011,000
Common Stock
Footnotes (5)
- [F1]Represents gift of 90,000 shares of common stock of Lev Pharmaceuticals, Inc. by Newton Partners, LLC to certain family members of Mr. Cooper. Mr. Cooper owns a 50% interest in Prism Ventures, LLC, which is the owner of Newton Partners, LLC.
- [F2]Represents gift of 90,000 shares of common stock of Lev Pharmaceuticals, Inc. by Newton Partners, LLC to Joshua D. Schein. Dr. Schein owns a 50% interest in Prism Ventures, LLC, which is the owner of Newton Partners, LLC.
- [F3]Consists of shares of common stock of Lev Pharmaceuticals, Inc. owned by certain family members of Mr. Cooper. Reflects gift of 30,000 shares of common stock by Newton Partners, LLC to certain of these family members.
- [F4]Shares of common stock reported are owned by Prism Ventures, LLC, and the following entities, all of which are owned by Prism Ventures, LLC: Newton Partners, LLC, Windsor Ventures, LLC, Sapphire Ventures, LLC, Tudor Technology Ventures, LLC and Entry Point Capital LLC.
- [F5]Includes 2,000,000 shares of restricted stock, all of which shares are subject to vesting requirements.
Documents
Issuer
Lev Pharmaceuticals Inc
CIK 0001144062
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001144062
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 7:20 PM ET
- Size
- 10.1 KB